[ Price : $8.95]
FDA says a Hologic 3/2024 recall correction of BioZorb Markers was Class 1.[ Price : $8.95]
UCB says it is ending the development of minzasolmin, a drug it was working on with Novartis to treat early Parkinsons disease, af...[ Price : $8.95]
FDA issues an alert against the use of certain Baxter Solution Sets with Duo-Vent Spikes because they were incorrectly assembled w...[ Price : $8.95]
FDA encourages drug sponsors to use centralized statistical monitoring to help keep an eye on clinical trial integrity issues.[ Price : $8.95]
Lawyers on a Food & Drug Law Institute enforcement panel warn that the incoming Trump administration is likely to target and seek ...[ Price : $8.95]
FDA says it has identified serious liver injuries in patients without cirrhosis of the liver being treated for primary biliary cho...[ Price : $8.95]
A detailed ProPublica investigative report says FDA failed to inspect a Glenmark Pharmaceuticals facility in India that had multip...[ Price : $8.95]
After receiving a complete response letter, Lykos Therapeutics says it will pursue FDAs dispute resolution process to question the...